01 16BAUSCH
02 1LACER PHARMA
03 3MAYNE PHARMA
01 28809307
02 18962028
03 110251895
04 110426787
05 210478502
06 110857159
07 110857159*PED
08 111020407
09 111648256
10 111679115
11 211839656
12 211957753
13 211986527
14 212076403
01 20Blank
01 14Y
02 6Blank
01 122031-11-02
02 12033-06-19
03 42036-06-06
04 22036-11-30
05 12037-05-30
Patent Expiration Date : 2031-11-02
US Patent Number : 10478502
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209355
Patent Use Code : U-2625
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-11-02
Patent Expiration Date : 2031-11-02
HALOBETASOL PROPIONATE; TAZAROTENE
US Patent Number : 10478502
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209354
Patent Use Code : U-2625
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-11-02
Patent Expiration Date : 2036-06-06
HALOBETASOL PROPIONATE; TAZAROTENE
US Patent Number : 10426787
Drug Substance Claim :
Drug Product Claim :
Application Number : 209354
Patent Use Code : U-2625
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-06-06
Patent Expiration Date : 2031-11-02
US Patent Number : 11986527
Drug Substance Claim :
Drug Product Claim :
Application Number : 209355
Patent Use Code : U-2625
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-11-02
Patent Expiration Date : 2036-06-06
HALOBETASOL PROPIONATE; TAZAROTENE
US Patent Number : 11648256
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209354
Patent Use Code : U-2625
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-06-06
Patent Expiration Date : 2036-06-06
HALOBETASOL PROPIONATE; TAZAROTENE
US Patent Number : 11679115
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209354
Patent Use Code : U-2625
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2036-06-06
Patent Expiration Date : 2031-11-02
HALOBETASOL PROPIONATE; TAZAROTENE
US Patent Number : 11839656
Drug Substance Claim :
Drug Product Claim :
Application Number : 209354
Patent Use Code : U-2625
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-11-02
Patent Expiration Date : 2031-11-02
HALOBETASOL PROPIONATE; TAZAROTENE
US Patent Number : 11986527
Drug Substance Claim :
Drug Product Claim :
Application Number : 209354
Patent Use Code : U-2625
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-11-02
Patent Expiration Date : 2031-11-02
US Patent Number : 11839656
Drug Substance Claim :
Drug Product Claim :
Application Number : 209355
Patent Use Code : U-2625
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-11-02
Patent Expiration Date : 2031-11-02
US Patent Number : 11957753
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 209355
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2031-11-02
